Rhythm Pharmaceuticals Rises on Positive Data for Prader-Willi Syndrome Treatment

The Boston-based pharmaceutical company said the Phase 2 trial showed that setmelanotide was effective in reducing body mass index and hyperphagia in patients with Prader-Willi syndrome, a genetic ...
Zacks Investment Research on MSN

Reasons to retain West Pharmaceutical stock in your portfolio for now

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by the robust GLP-1-related demand and expansion plans. However, pricing headwinds and tariff risks are concerning. Shares ...

Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...

Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006

LNK01006 recently received IND clearance from the FDA to initiate first-in-human studies in the US. Formation Bio plans to initiate a Phase 1 study in the first half of 2026, reflecting the company's ...

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET on Thursday, December 11 to discuss this update. Participants may register for the conference call here. It is ...
BioSpace

Japanese Pharmas Looking Beyond Borders for M&A to US, EU

Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.

Madrigal Pharmaceuticals moving to larger Montgomery County space as workforce balloons

Preview this article 1 min Madrigal Pharmaceuticals is moving to a new 54,000-square-foot headquarters as its workforce nears ...
Healio

Resmetirom upholds liver stiffness, biomarker gains in MASH cirrhosis at 2 years

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Resmetirom maintained meaningful improvements in MASH ...
Boston Herald

Trump finds new trade targets — pharmaceuticals, kitchen cabinets and heavy trucks

Naturepedic, a mattress and furniture company based outside Cleveland, has been planning to introduce an upscale upholstered headboard late this year or early in 2026. But President Donald Trump has ...
WCVB Channel 5 Boston

5 for Good: Vertex's paid internship benefits Boston students

OF THE AREA MEDIAN INCOME. A GLOBAL BIOTECH COMPANY IS FOSTERING TALENT AMONG BOSTON PUBLIC SCHOOL KIDS. OUR ERIKA TARANTAL REPORTS ON THE PAID INTERNSHIP PROGRAM, GIVING STUDENTS THE OPPORTUNITY OF A ...
AZ Central

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 MIAMI, FL / ACCESS Newswire / June 2, 2025 / ...